000179679 001__ 179679
000179679 005__ 20180913061419.0
000179679 02470 $$2ISI$$a000251705800085
000179679 037__ $$aCONF
000179679 245__ $$aClinical experiences with therapeutic derivatives of the anti-ED-B fibronectin immunoprotein L19
000179679 269__ $$a2007
000179679 260__ $$c2007
000179679 336__ $$aConference Papers
000179679 700__ $$aSpitaleri, G.$$uIst Europeo Oncol, Milan, Italy
000179679 700__ $$aCurigliano, G.$$uIst Europeo Oncol, Milan, Italy
000179679 700__ $$aDePas, T.$$uIst Europeo Oncol, Milan, Italy
000179679 700__ $$aNoberasco, C.$$uIst Europeo Oncol, Milan, Italy
000179679 700__ $$aPaganelli, G.$$uIst Europeo Oncol, Milan, Italy
000179679 700__ $$aGiovannoni, L.$$uPhilogen SpA, Siena, Italy
000179679 700__ $$aZardi, L.
000179679 700__ $$aNeri, D.$$uSwiss Fed Inst Technol, Lausanne, Switzerland
000179679 700__ $$aMenssen, H.
000179679 700__ $$aDe Braud, F.$$uIst Europeo Oncol, Milan, Italy
000179679 7112_ $$aAnnual Meeting of the EORTC-NCI-ASCO on Molecular Markers in Cancer$$cBrussels, BELGIUM$$dNov 15-17, 2007
000179679 773__ $$j5$$q33-33$$tEjc Supplements
000179679 909C0 $$0252369$$pSB$$xU10077
000179679 909CO $$ooai:infoscience.tind.io:179679$$pconf$$pSB
000179679 937__ $$aEPFL-CONF-179679
000179679 973__ $$aEPFL$$sPUBLISHED
000179679 980__ $$aCONF